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Abstract
Background: People with inflammatory rheumatological conditions (IRCs), are at increased risk of comorbidities such as
cardiovascular disease, osteoporosis, anxiety and depression. The INCLUDE pilot trial evaluated a nurse-delivered review
of people with IRCs which sought to identify and initiate management of comorbid conditions.
Aim: A nested qualitative study was undertaken to examine the acceptability of the INCLUDE review.
Methods: A qualitative interview-based design in UK primary care settings. A purposive sample of 20 patients who attended
an INCLUDE review, were interviewed. Inductive thematic analysis was undertaken. Themes were agreed through multi-
disciplinary team discussion and mapped onto constructs of the Theoretical Framework of Acceptability (TFA).
Results: Six themes mapped onto six of the seven TFA constructs. Patients reported the review to be effective by
identifying and initiating management of previously unrecognised comorbid conditions. Some participants reported
barriers to following recommendations, such as lifestyle modifications or taking more medication.
Conclusion: A nurse-delivered review to identify comorbidities is acceptable to patients with IRCs. The TFA provided a
novel analytical lens.
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Introduction
Inflammatory rheumatological conditions (IRCs) include
rheumatoid arthritis (RA), psoriatic arthritis (PsA), anky-
losing spondylitis (AS), polymyalgia rheumatica (PMR)
and giant cell arteritis (GCA). People with IRCs are at an
increased risk of comorbidities such as cardiovascular dis-
ease (CVD), osteoporosis and depression,1–6 which are key
NHS priorities.7 Despite people with IRCs being at
increased risk of these morbidities they are often poorly
managed,8 leading to increased morbidity and mortality.
At present, proactive monitoring of people with IRCs is
not routine, except for RA, where an annual review is a
target within the Quality and Outcomes Framework
(QOF).9 The content of the review is not specified by QOF,
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although NICE guidance10 advocates a ‘holistic assess-
ment’. These reviews are often fragmented across primary
and secondary care, resulting in duplication of some activi-
ties (with cost implications), for example, for CVD whilst
other morbidities remain unrecognised and untreated.11,12
Review of patients with other IRCs does not routinely occur.
We undertook a pilot cluster randomised controlled
trial with a qualitative process evaluation to test the fea-
sibility and acceptability of a nurse-delivered primary
care review for patients with IRCs to identify and assess,
plus provide advice and signposting, for common comor-
bidities including anxiety and depression, and risk of car-
diovascular disease and fragility fracture. Patients were
provided with an individualised management plan.13 The
INCLUDE study protocol paper13 provides details of the
INCLUDE intervention.
An intervention that is not acceptable to those receiving
or delivering it is not useful in clinical practice. Qualitative
methods play an important role in investigating acceptability
of intervention components or trial procedures.14 However,
the term ‘acceptability’ is vague, and until recently there has
been little guidance on how to specify acceptability. The
theoretical framework of acceptability15 defines acceptabil-
ity as ‘a multi-faceted construct that reflects the extent to
which people delivering or receiving a healthcare interven-
tion consider it to be appropriate, based on anticipated or
experienced cognitive and emotional responses to the inter-
vention’. The TFA consists of seven constructs: affective
attitudes, intervention coherence, perceived effectiveness,
burden, self-efficacy, opportunity-costs, and ethicality. The
aim of our study was to examine the acceptability of the
INCLUDE review using the TFA theory as an analytical tool
for the first time in a feasibility trial.
Methods
Study setting, sampling and recruitment
The study setting was UK primary care. A sample of parti-
cipants (n ¼ 55) who attended an INCLUDE review were
invited (by mail) to participate in a semi-structured inter-
view. Participants were purposively recruited to include a
range of gender, age, and IRCs (RA, PsA, AS, PMR or
GCA). Attempts were made to collect data to the point
where ‘new’ data did not further develop the outcome of
the analysis. All interviews were undertaken by an experi-
enced qualitative researcher (DH). Written informed con-
sent was obtained prior to each interview. DH was not
previously known to the participants as part of the
INCLUDE study. NHS Research Ethics Committee
approval was obtained (Ref: 17/WA/0427).
Study design
An interpretivist research paradigm underpinned this study,
with the research team recognising that findings were
underpinned by multiple, subjective realities, and were
influenced by the interaction between participants and the
researcher/s. Therefore, this research study aimed to cap-
ture these subjective experiences of the INCLUDE review
through a qualitative methodology.
Semi-structured interviews were conducted with partici-
pants using a topic guide, developed by the study team and
informed by a patient advisory group (PAG). This group,
consisting of six patients with different IRCs, gave sugges-
tions on re-phrasing questions to make them more accessi-
ble. The topic guide included questions that would help the
team identify if there were aspects of the trial processes or
intervention components that needed to be changed before
proceeding with the next phase of evaluation. Questions
were about experiences of inflammatory conditions, engage-
ment with specific components of the intervention, what
participants liked and did not like and why, what happened
as a result of the review and if there was anything missing
from the review. The guide was refined during data collec-
tion and analysis, to better capture the participants’ experi-
ences and views of acceptability.
Face-to-face interviews took place either within the par-
ticipant’s home or at their general practice. All interviews
were digitally audio-recorded and transcribed verbatim by
an independent transcription company. Transcriptions were
checked against the audio-recording and anonymised.
Interviews lasted between 30–121 minutes (average of 58
minutes).
Analysis
Analysis started as soon as the first interview was tran-
scribed. Data were analysed using Inductive Thematic
Analysis and constant comparison.16,17 Data, codes, sub-
themes, and themes were constantly compared with one
another within and across transcripts. Codes and themes
were defined by an experienced multidisciplinary team.
To further understand patient acceptability, subthemes
were then mapped onto the constructs of the TFA.15
Trustworthiness
Procedures were implemented to better ensure the trust-
worthiness of this research.18 For example, investigator
triangulation helped to promote credibility. Codes and
themes were defined by an experienced multidisciplinary
team. Details of the study setting was described, and illus-
trative quotes used to support interpretations to better
ensure transferability of the findings. To help ensure con-
firmability, an audit trail across data collection, analysis
and the interpretation of data, was recorded.
Results
20 participants (16 females and 4 males) with a mean age of
68 years old (range 35–80 years) were interviewed, most in
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the 70–79 age category (n ¼ 12). This age and gender
profile is the same as that for all participants in the pilot
trial. Table 1 provides participant demographic informa-
tion. A broad spread of participants according to type of
IRC was achieved.
Through the thematic analysis, six themes were devel-
oped: Expectations of the Review; Experiences of the
Review; Outcomes; Burden; Wanting to Focus on their
Priority; and Barriers. These six themes and their sub-
themes mapped onto six of the seven TFA constructs,
including affective attitudes, intervention coherence, per-
ceived effectiveness, burden, self-efficacy, and opportunity-
costs (see Online Appendix A for data mapping). It was
recognised that some of the sub-themes represented more
than one TFA construct; where this occurred, the data were
presented under the construct which best represented that
data. The results are reported under the constructs of the
TFA. Illustrative data is presented to support each construct.
Affective attitudes
Affective attitudes, the participants’ feelings towards the
INCLUDE review, was the most prominent construct
within the data and included reasons for participating,
thoughts about the different components of the review,
thoughts about the outcome/s of the review, and the timing
of the review.
Participants felt positive about how the review made
them feel, how it was undertaken and what it contained.
Several participants felt that being invited to the INCLUDE
review indicated that someone cared about them and that
they were being listened to:
I think these things are showing that somebody cares . . .
You’re not just a name on the list. (P14)
Most participants recognised that the case-finding ques-
tions and assessments for the comorbid conditions were
relevant to them, and important to inform review outcomes:
[Case-finding questions] important to pick that up because
sometimes you can talk about how the condition makes you
feel . . . those questions kind of make you be more frank and I
think probably enabled the nurse to recognise whether more
support is needed or not as well. (P3)
Furthermore, several participants identified the emo-
tional impact of their IRC and felt the case-finding ques-
tions for depression and anxiety provided an important
opportunity to discuss their feelings:
. . . I think it is quite important, if only from sort of the mental
side of being able to discuss things . . . Talking about your
mood and how you feel ‘cause it can have a bearing on all
sorts of things, can’t it? Especially if you’re feeling down.
(P20)
However, a few participants reported feeling uneasy
answering questions about their mood or broader physical
health within the review:
[Mood case-finding questions] made me feel a bit anxious
really ‘cause I don’t really tell people that I’m in pain. I don’t
really tell people how I’m feeling. (P10)
Participants valued the personal qualities of the nurses
who delivered the INCLUDE review, mentioning qualities
such as their approachability or ability to listen, which
made them feel comfortable, and helped them more openly
discuss their health within the review consultation:
The nurse was willing to listen . . . they actually smiled at me;
it made me feel happy and didn’t make me feel like I was being
judged . . . their overall demeanour was really nice and war-
ming . . . It just made me feel more relaxed, being able to then
say what I wanted to say without being judged. (P1)
Participants highlighted that feeling comfortable within
the review was important when potentially sensitive ques-
tions were asked, such as those for mood:
. . . cause they were calm. You know, they were saying, ‘Well,
it doesn’t matter. You know, just tell me how you
feel.’ . . . they weren’t pressurising me. They were a bit more
calming influence . . . They didn’t get agitated with me or any-
thing which was quite good. (P13)
Participants also described the usefulness of the
INCLUDE summary sheet, which summarised key actions







1 30–39 F RA
2 70–79 F RA
3 40–49 F PsA
4 70–79 F RA
5 70–79 F PMR, GCA
6 50–59 F PsA
7 70–79 F PMR
8 80–89 M RA. PMR
9 70–79 M AS
10 50–59 F PsA
11 50–59 F PsA
12 70–79 F AS
13 70–79 F PMR
14 70–79 M GCA
15 70–79 F PMR
16 60–69 F RA
17 60–69 F PMR
18 70–79 M AS
19 70–79 F AS
20 70–79 F RA
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from the review (e.g. make an appointment with their GP)
and signposting to other services:
. . . we’ve looked at it a couple of times [INCLUDE summary
sheet], to see, you know, on the other side it shows you dif-
ferent things that we’ve not heard of where you could go and
look online and that . . . you know they’ve pinpointed us in the
right direction if I need anything where I can phone and
go. (P6)
Most participants described feeling pleased about the
outcome of the review; feeling that the advice, recommen-
dations, and/or signposting given by the nurse were useful,
and relevant to them:
Essential I think [having an GP appointment made for low
mood], really appropriate, it was needed, yeah, so it was the
right guidance, the right advice, you know, so it was really
good. (P3)
However, not all participants were receptive to the
nurse’s recommendation, relating particularly to low mood
and high cholesterol. Two participants did not feel their
recommendation from the review was correct:
I thought that was absolutely ridiculous [mild depression iden-
tified], cause I don’t, I get angry at things, but no more than
anybody else does. (P16)
I could have them [statins] but I’m not interested in
taking anything ‘cause I think they like it around five and
it was 5.3, something like that. So to me that didn’t seem
enough to start taking something that I probably didn’t
need really. (P17)
For a few participants, who had experienced little recent
impact from their IRC or other health conditions, there was
a sense that the review did not come at the right time for
them, making it seem less relevant:
I haven’t had symptoms for a long time, really severe symp-
toms for a very long time so I was a bit surprised [at being
invited] . . . I felt a bit of a fraud because I wasn’t . . . as I said I
had had some stiffness, which is fine. (P3)
Burden
Burden refers to ‘the perceived amount of effort that is
required to participate in the intervention’.15 Most partici-
pants did not report the review as being burdensome. How-
ever, a few participants found that the suggestions of new
medications to deal with newly identified comorbidities
added extra treatment burden:
I don’t want to take anymore [medication]. Cause with cho-
lesterol, is it creams and things and butter and fat . . . I can cut
that down myself without having another tablet . . . The less
tablets I take, the better. (P16)
One participant suggested that the review added burden
when additional appointments were suggested to monitor
an existing comorbidity which the participant had recently
had reviewed:
They asked me to see the nurse because when they took the
reading, it was high. I wish [the nurse] hadn’t done that
because I was already being treated for that and had been quite
recently so I didn’t feel as though I needed that but you
know . . . so I didn’t feel as though I needed that. (P11)
Intervention coherence
Intervention Coherence is the extent to which the partici-
pants understand the intervention, including the purpose of
the INCLUDE review and what it entailed, and their
increased risk of comorbid conditions.
Prior to attending their review, many participants were
unsure of the focus of the INCLUDE review:
I didn’t know what to expect . . . I didn’t realise they were
going to talk to me about the other underlying conditions that
I can have. (P10)
This uncertainty may have been influenced by the par-
ticipants’ lack of awareness and knowledge of their
increased risk of comorbid conditions. Many participants
lacked awareness of some of the comorbid conditions they
were at an increased risk of developing, and which they
discussed within the review:
I mean not really. They didn’t really tell me what things it
could involve, the actual disease itself . . . (P17)
However, after experiencing the review, participants
reported a new understanding of the purpose and content
of the review, as illustrated by participants when describing
the integrative nature of the review and/ or when comparing
the INCLUDE review and the reviews they receive for
other health conditions (e.g. diabetes) or their IRC:
. . . it included the whole of your wellbeing and not just
your symptoms of what’s wrong. I thought it was good-
Just managed to touch on everything. Cause it isn’t that
long an appointment, but we seem to get quite a lot done.
(P6)
Opportunity costs
Opportunity Costs are defined as ‘the extent to which ben-
efits, profits, or values must be given up to engage in an
intervention’.15 Most patients did not need to give up ‘ben-
efits, profits, or values’ to participate in INCLUDE. How-
ever, a small number of participants illustrated the
opportunity costs of participating as they felt that the out-
come from the INCLUDE review interfered with their per-
sonal priorities:
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I think it could be a bit complicated if you were trying to cope
with you know two things . . . let’s get one thing sorted and
then let’s start on another thing. (P15)
A minority of participants suggested that they did not
want to have further problems identified:
I don’t want to think about it [comorbid conditions] . . . I’ve got
enough with that one [partner] . . . it scares me a little bit, let’s
put it that way. It frightens me a little bit because if he’s still
alive, I won’t be able to look after him. (P19)
Perceived effectiveness
Perceived Effectiveness refers to ‘the extent to which par-
ticipants perceive the intervention as achieving its pur-
pose’.15 Participants’ perceived the INCLUDE review to
be effective as it identified their risk of comorbidities,
increased knowledge of their risk of comorbidities and how
this could be mitigated. Most participants reported the
review to have been helpful in identifying and initiating
management of previously unrecognised comorbidities:
. . . it’s flagged a few things up with the doctors that have just
let things slide, regarding me, yeah and now I’m on top of it
all. (P6)
The nurse said that, you know, ‘perhaps you could go to
your doctors, I can’t authorise a scan for brittle
bones’ . . . (P16).
Fewer participants highlighted the case-finding ques-
tions as identifying low mood, and the nurse signposting
the participant to appropriate services to discuss their mood
or arranging an immediate appointment with their GP:
The nurse identified a need for me to see the doctor, so
they just said I think it would be a really good idea, why
don’t you stay and see . . . they went straight out to see if I
could see the doctor straight away so I didn’t have to do
anything. (P3)
The review was perceived as being effective by reassur-
ing participants when a low risk of additional problems was
fed back to them. These participants interpreted this as
indicating that they were already effectively managing
their health:
it’s nice to have that reassurance that you’re doing as much for
yourself as you can, you know. (P17)
Participants also identified how participating in the
INCLUDE review was effective by increasing their aware-
ness and understanding of their risk of comorbid conditions
and how they can lower their risk:
. . . it highlighted things perhaps and made it more real you
know and talking about, just probably you know informing
me . . . reminding me of the risks as well of the condition and
what I can do to lower those risks as well. (P3)
Self-efficacy
Self-efficacy refers to ‘the participant’s confidence that
they can perform the behaviour(s) required to participate
in the intervention’.15 As seen above participants found the
review increased their understanding and awareness of
comorbid conditions. Many participants were unaware of
this risk until participating in the study. This awareness and
understanding, whether a comorbid condition was newly
identified or not, allowed patients to act indicating good
self-efficacy. Although low self-efficacy was not a promi-
nent feature of the data, there were a few examples where
participants felt unable to follow through with the
INCLUDE nurses’ recommendations:
I do a bit – be a bit more active which sometimes, I find a bit
difficult . . . ’cause it’s painful, so I don’t walk out now like –
not like I used to . . . in fact, I rarely go out, unless we go in the
car. I mean I go and do the shopping, but I won’t walk to the
shops. We’ll go in the car; that sort of stuff. (P 20)
Discussion
Summary
This qualitative study investigated acceptability of a new
primary care integrated nurse-led review for patients with
IRCs. We have used a novel approach by applying the
TFA as an analytical lens, allowing a multidimensional
and detailed investigation of acceptability. Six of the
seven TFA’s constructs were identified within the data
(affective attitudes, intervention coherence, perceived
effectiveness, burden, self-efficacy and opportunity-
costs). The findings illuminate the acceptability of an
integrated primary care nurse-led review from the
patient’s perspective, and have illustrated areas of further
development, including enhancing INCLUDE nurse train-
ing. This study contributes to the rapidly growing litera-
ture around TFA and has implications for the presentation
of the TFA findings, including presenting it in a more
dynamic model to illustrate interconnectedness and sig-
nificance of constructs for the proposed intervention. The
implications and recommendations are discussed in more
detail under the implications section.
Strengths and limitations
A key strength of this research study was the method of
analysis and procedures used to better ensure trustworthi-
ness of data.18 For example, inductive thematic analysis
helped to maintain the participants’ voices and grounded
the findings in the participant data. Subsequent deductive
mapping of themes and subthemes to the TFA further
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interrogated the data and provided deeper insight into
acceptability through its multiple constructs.
We interviewed a sample of participants from the
INCLUDE trial. However, those who did not find the
review acceptable may not have agreed to participate in
interviews. However, overall in the pilot INCLUDE trial,
there was good uptake of the INCLUDE intervention as
76% of those invited came to a review.
We only report on the perspectives of patients, and these
need to be considered alongside perspectives of the nurses
delivering the intervention. Analysis of interviews with
nurses and general practitioners is ongoing and will be
reported separately.
Comparison with existing literature
The TFA is fast gaining recognition in health research and
has been used throughout studies in different ways, includ-
ing: to highlight how their findings were in line with TFA
constructs19–25; in aspects of study design or analysis26–30;
and in protocol papers outlining how they will use the TFA
in future.31–34 Unlike this study, Nadarzynski et al.27 used
the TFA to inform questions on a topic guide about accept-
ability of artificial intelligence led chatbox services; how-
ever, they did not analyse the data using the TFA.
Like our study, other studies have used the TFA to ana-
lyse their data. For example, Jan-Kuriawati et al.28 used
TFA constructs to guide thematic analysis of data in a
qualitative study of private practitioner’s views of manda-
tory tuberculosis notification in Indonesia and report 4 TFA
constructs in their data. Murphy et al.29 also applied the
TFA as a coding scheme to analyse data from interviews
with Community Pharmacists on acceptability of a men’s
mental health promotion programme, and report effective-
ness of the intervention, burden, and self-efficacy as the
most commonly occurring constructs.
Some studies have proposed new acceptability domains.
Jan-Kuriawati et al. identified external and environmental
factors of acceptability.28 Mukunya et al. suggested that
social and cultural dimensions of acceptability are under-
valued currently in the TFA.30 Our study has also contrib-
uted to the development of the TFA, recommending the
TFA findings be presented in a more dynamic model to
illustrate interconnectedness and significance of constructs
for the proposed intervention (see Figure 1). As only two of
the original 43 reviews used to develop the TFA were
qualitative reviews,15 future qualitative studies will have
an important role in providing and then assessing new
insights on acceptability domains and adding to the model
as it is used in wider contexts and settings.
Implications
Optimising acceptability of the include review. This work iden-
tified a few areas for optimisation of the INCLUDE review
ahead of a larger evaluation. These can mostly be addressed
through enhancing the nurse training programme as
follows:
 Recognition that patients may feel concerned dis-
cussing the depression and anxiety case-finding
questions (Affective Attitudes)
 Clarification that risk of comorbidities is not neces-
sarily related to current inflammatory activity of the
IRC (Coherence)
 Discussion of the potential impact of increased med-
ication required for newly identified conditions or
risks (Burden) and how patient’s existing priorities
may be impacted by the review (Opportunity Cost)
 Reinforcement of strategies to check how the patient
feels about following recommendations made in the
review and to determine their confidence in attempt-
ing lifestyle changes (Self-efficacy)
Reflections on the use of the Theoretical Framework of
Acceptability (TFA). The TFA theory provided a useful
analytical framework by allowing a more in-depth and
multi-dimensional, theoretically informed analysis of
acceptability. Sekhon et al. present the constructs of the
TFA in alphabetical order in a linear model and outline the
extent to which they may cluster or influence each of
the temporal assessments of acceptability is an empirical
question.15 Our study has illustrated that the constructs are
interconnected, not isolated and constructs exerted influ-
ence over one another. For example, patients’ perceptions
that recommendations from the nurse added extra burden
(Burden), influenced how they felt towards the review
(Affective Attitudes).
Though the TFA’s constructs represented in these find-
ings were important for assessing acceptability of the
INCLUDE study, some were more populated than others.
No data were mapped to the TFA construct of ethicality;
though the lack of findings linked to ethical issues may be
explained by the topic guide not being generated using TFA
constructs.
We recommend presenting TFA findings in a more
dynamic model to illustrate interconnectedness and signif-
icance of constructs for the proposed intervention as illu-
strated in Figure 1. Instead of a linear representation of the
constructs we have used a ring. Larger circles represent
constructs that were well presented in the dataset, smaller
circles had less data, and those greyed out had no data.
Arrows show the direction of influence between constructs.
The approach is applicable to all studies using the TFA. In
the INCLUDE study all constructs identified in the data
exerted influence on affective attitudes. In a study of pro-
spective acceptability of giving smoking cessation advice
at the point of cervical screening, Mansour et al.19 found
that expected interaction (quality of communication)
between the person delivering and the person receiving the
intervention would influence affective attitude. Our study
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supports links with all TFA constructs and affective atti-
tude in a retrospective analysis (after the intervention has
been experienced). Other studies may find different links.
Conclusions
The nurse-led review, aimed at identifying previously hid-
den comorbidities, was acceptable to patients with IRCs,
participating in a pilot trial. Patients reported feeling cared
for, and valued the components of the review, including the
opportunity to discuss their health more broadly. There
were few examples of reported burden, opportunity costs,
and low self-efficacy. The theoretical framework of
acceptability was useful in providing an in-depth and
multi-dimensional analysis. Whilst this analysis is vital
preparation for a fully-powered randomised controlled
trial, there are also implications for clinical practice. Iden-
tifying and managing people with multimorbidity is an
increasing challenge for primary care and recognising
additional comorbidities in people with LTCs is key to
improving patient outcomes. We have demonstrated that
case-finding for additional morbidities is acceptable to
patients, who are then willing to take on further work35
in self-managing identified conditions.
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